Pricing Log in Create free account

Iterum Therapeutics PLC (ITRMF) vs Virax Biolabs Group Limited (VRAX)

Iterum Therapeutics PLC and Virax Biolabs Group Limited are both Biotechnology companies. Iterum Therapeutics PLC and Virax Biolabs Group Limited are of similar size ($1.6M and $1.6M). Virax Biolabs Group Limited has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 10 metrics below, Virax Biolabs Group Limited leads on 6 and Iterum Therapeutics PLC on 4.

Valuation

Metric ITRMF VRAX Biotechnology median
P/E n/m n/m 10.60
P/S n/m — 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.86 0.66
EV/Sales 24.37 n/m 9.02
Earnings yield 0.00% (642.17%) (32.88%)
Free cash flow yield 0.00% 0.00% (23.13%)

Profitability

Metric ITRMF VRAX Biotechnology median
Gross margin (81.85%) — 68.51%
Operating margin (2,243.48%) — 0.00%
Net margin (2,930.54%) 0.00% 0.00%
Free cash flow margin (2,122.61%) 0.00% 0.00%
Return on equity 285.48% 0.00% (51.96%)
Return on assets (111.35%) 0.00% (46.06%)
Return on invested capital (455.51%) 0.00% 0.00%

Growth

Metric ITRMF VRAX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 57.43% 68.79% 29.88%
Revenue growth, 5-year CAGR — (36.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ITRMF VRAX Biotechnology median
Debt to equity (2.87) 0.00 0.00
Current ratio 2.13 9.97 4.97
Net debt to EBITDA 0.24 1.08 1.01

Dividend

Metric ITRMF VRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ITRMF VRAX Biotechnology median
Market cap 1.59m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack